TUESDAY, July 22 (HealthDay News) -- Patients with hepatitis C who receive a liver from a donor over age 60 aren't at an increased risk for transplant failure, death or recurrent disease within five years after transplantation, say researchers at the Washington University School of Medicine, in St. Louis.

They analyzed data from 489 adults who had liver transplants at the school between 1997 and 2006. Of those patients, 187 (38.2 percent) had hepatitis C and 302 (61.8 percent) had other indications for liver transplant.

WEDNESDAY, July 16 (HealthDay News) -- In a feat that should help researchers more effectively evaluate new treatments for hepatitis C, investigators report that they have developed the first tissue culture of regular human liver cells that can imitate infections with the hepatitis C virus (HCV).

THURSDAY, May 29 (HealthDay News) -- One glass of wine a day may not only be safe for the liver, but may actually reduce the risk of non-alcoholic fatty liver disease (NAFLD), according to a new study that challenges conventional wisdom.

The population-based study, from researchers at the University of California, San Diego, included 7,211 nondrinkers and 4,543 modest alcohol drinkers (an average of four ounces of wine, 12 ounces of beer, or one ounce of liquor per day) found that those who drank one glass of wine a day had half the risk of suspected NAFLD compared to nondrinkers.

I was in a car accident and suffer from herniated disks and arthritis of my spine. As life changing enough as that is when I received the report from my CT Scan they had other news to tell me as well. I have a liver disease. When the doctor explained how serious this could be and that I need to go to a specialist for further examination because I'm too young (22 years old) for this type of problem I became overwhelmed by emotion, but needed to find out all I could on my condition.

THURSDAY, March 6 (HealthDay News) -- Chronically high blood glucose levels disable the molecular switch that normally turns off sugar production in the liver in response to increasing insulin levels, a California study finds.

By Steven Reinberg HealthDay Reporter THURSDAY, Feb. 14 (HealthDay News) -- Scientists have shown that transplanting healthy liver cells into mice with hemophilia enables the animals to produce a critical clotting factor missing in humans with type A hemophilia. The breakthrough finding may lead the way to a cure for type A hemophilia, the most common type of the disease, researchers believe.

(HealthDay News) - Jaundice occurs when excess bilirubin builds up in the liver, causing the skin and whites of the eyes to develop a yellowish tint. Bilirubin is produced when hemoglobin from red blood cells is broken down by the body.

The Cleveland Clinic offers these possible causes of jaundice:

* A tumor or gallstone obstructing a bile duct.
* Inflammation of the liver (hepatitis).
* A narrowing of a bile duct.
* Cirrhosis of the liver.
* Pancreatic cancer.
* Insufficient blood supply to the liver.